Thursday, April 4, 2013
This week in techniques
Publication and contact
Trifluoromethyloxadiazole (TFMO)-containing compounds to identify
class IIa histone
compounds could be used as research compounds to guide development of class
IIa HDAC inhibitors. Genetic associations have been identified between class
IIa HDACs and Huntington's disease (HD), glucose homeostasis, muscular
dystrophies, autoimmunity and ischemic stroke. A screen of about 2 million
compounds from GlaxoSmithKline
plc's diversity collection identified compounds with HDAC9
inhibitory activity, with 3 of the 4 most potent hits containing the TFMO
chemical group. In inhibition assays of HDACs 1-11, the top hit showed
preferential inhibition of class IIa HDACs and did not cause cell toxicity.
Next steps at Tempero
Pharmaceuticals Inc. and GSK include using the research
compounds to evaluate the therapeutic potential of class IIa HDACs in
autoimmune diseases (see Closer to class IIa HDAC inhibitors,
Published online April 4, 2013
Patent status undisclosed;
Tempero is interested in collaboration opportunities
Lobera, M. et al. Nat.
Chem. Biol.; published online March 24, 2013;
Contact: Michael A. Nolan, Tempero Pharmaceuticals Inc., Cambridge,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]